Resources

Nanopharm Resources

As a leader in the field of developing and testing nasal and inhaled drug delivery products, Nanopharm is committed to advancing scientific knowledge in this specialized area. Our team of dedicated scientists conduct cutting-edge research, and we are excited to share our content with you. By sharing our scientific publications webinars and white papers, we aim to foster a spirit of collaboration, inspire new ideas, and contribute to the collective knowledge of the OINDP scientific community. We encourage you to explore our resources page but please visit this section at regular intervals as our team continues to share the latest scientific articles with you.

11 February 2025

Advancing Alternative Bioequivalence for OINDPs

Bioequivalence, Nanopharm, OINDPs

27 Sep 2023

Analytical Services, Inhalation, Nasal

27 Sep 2023

Inhalation, Nasal

01 Jun 2023

bioequivalence, Nanopharm, OINDP, PBPK modelling, Pharmacokinetic, SmartTrack

01 Dec 2022

Drug Product, Generic, Inhalation, OINDP, Pharmaceutical regulatory

14 May 2022

Accelerate Development, drug delivery, Formulation Development, Nanopharm, OINDP, Respiratory, Risk Mitigation, SmartTrack

11 May 2022

Biologics, COVID-19, Nasal, Nasal Delivery, therapeutics

01 May 2022

bioequivalence, Drug Development, Drug Solubility, In Vitro, In Vivo, Nanopharm, OINDP, Pharmacokinetics

15 Apr 2022

drug formulation, formulation and development, Nasal

14 Apr 2022

Biologics, drug delivery, Drug Development, Nanopharm, Nasal, SARS-CoV-2